Allison Swartz sold $119k of PGNY
EVP, GC at Progyny, Inc.. 6,856 shares at an average of $17.36, traded Mar 2, 2026, filed Mar 4, 2026.
Score components
- +15RoleOfficer
- +10Trade size$119k at market
- 0Share of holdings soldSold 6.9% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -6.7%, 3m +40.5%, 6m +47.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001551306-26-000031, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 2, 2026 | AGrant or award Common Stock10b5-1 | +28,409 | $0.00 | $0 | 101,128 | Mar 4, 2026 |
| Mar 2, 2026 | FTax withholding Common Stock10b5-1 | -1,551 | $17.69 | $27k | 99,577 | Mar 4, 2026 |
| Mar 2, 2026 | SOpen-market sale Common Stock10b5-1 | -2,199 | $17.27 | $38k | 97,378 | Mar 4, 2026 |
| Mar 3, 2026 | FTax withholding Common Stock10b5-1 | -2,842 | $17.60 | $50k | 94,536 | Mar 4, 2026 |
| Mar 3, 2026 | SOpen-market sale Common Stock10b5-1 | -500 | $17.40 | $8,698 | 94,036 | Mar 4, 2026 |
| Mar 3, 2026 | SOpen-market sale Common Stock10b5-1 | -4,157 | $17.40 | $72k | 89,879 | Mar 4, 2026 |
| Mar 2, 2026 | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +41,430 | $0.00 | $0 | 41,430 | Mar 4, 2026 |
Related signals
Other insiders at Progyny, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 13Weak | Progyny, Inc. | Allison Swartz EVP, GC | $102k 3,903 shares | -5% | |
| 42Moderate | Progyny, Inc. | Kevin K Gordon director | $312k 11,500 shares | -63% | |
| 42Moderate | Progyny, Inc. | Kevin K Gordon director | $321k 11,500 shares | -63% | |
| 8Weak | Progyny, Inc. | Melissa B Cummings Chief Operating Officer | $71k 2,244 shares | -3% | |
| 25Weak | Progyny, Inc. | Mark S. Livingston CHIEF FINANCIAL OFFICER | $64k 2,517 shares | -3% | |
| 16Weak | Progyny, Inc. | Allison Swartz EVP, GC | $45k 1,798 shares | -2% | |
| 21Weak | Progyny, Inc. | Geoffrey Clapp Chief Product Officer | $39k 1,530 shares | -3% | |
| 17Weak | Progyny, Inc. | Mark S. Livingston CHIEF FINANCIAL OFFICER | $7,310 279 shares | -0% | |
| 37Weak | Progyny, Inc. | Cheryl Scott director | $196k 7,439 shares | -27% | |
| 17Weak | Progyny, Inc. | Allison Swartz EVP, GC | $61k 2,398 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.